Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice. [electronic resource]
Producer: 20150330Description: 1450-1459 p. digitalISSN:- 1525-0024
- Animals
- Dependovirus -- genetics
- Disease Models, Animal
- Genetic Therapy -- methods
- Genetic Vectors -- administration & dosage
- Humans
- Injections, Intravenous
- Insulin-Like Growth Factor I -- administration & dosage
- Liver -- metabolism
- Mice
- Muscular Atrophy, Spinal -- blood
- Survival of Motor Neuron 1 Protein -- genetics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.